Home » Trials » SLCTR/2013/012


Randomized controlled trial on the safety of using laryngeal mask airway (LMA), compared to endotracheal tube (ETT) for myringoplasty and mastoid surgery taking less than one and half hours in adults

-

SLCTR Registration Number

SLCTR/2013/012


Date of Registration

22 Mar 2013

The date of last modification

Mar 03, 2019


Trial Status



Application Summary


Scientific Title of Trial

Randomized controlled trial on the safety of using laryngeal mask airway (LMA), compared to endotracheal tube (ETT) for myringoplasty and mastoid surgery taking less than one and half hours in adults


Public Title of Trial

A study comparing safety of two types of tubes used for anaesthesia in ear surgery


Disease or Health Condition(s) Studied

Anaesthesia in myringoplasty and mastoid surgery


Scientific Acronym

None


Public Acronym

None


Brief title

None


Universal Trial Number

None


Any other number(s) assigned to the trial and issuing authority

EC-12-036 (Ethics Review Committee of the Faculty of Medicine, University of Colombo)


Trial Details


What is the research question being addressed?

Anaesthesia in myringoplasty and mastoid surgery


Type of study

Interventional


Study design

Allocation

Randomized controlled trial


Masking

Masking not used


Control

Active


Assignment

Parallel


Purpose

Treatment


Study Phase

Not Available


Intervention(s) planned

All patients will be premedicated with diazepam 5mg nocte and mane, metoclopramide 10 mg and omeprazole 40 mg on the preceding evening then 40 mg 2–6 hours before surgery. Anaesthesia will be induced with propofol 2.5mg/kg , fentanyl 100mg intravenously. At loss of eyelid reflex, atracurium 0.5mg/kg will be administered intravenously. Patient will be mask ventilated for 3minutes with 30% Oxygen, 70% N2O and isoflorane then either a LMA or ETT will be inserted to secure the airway.

In the LMA group size 3 LMA will be used for females and size 4 will be used for males. 5ml and 10 ml of air will be used to inflate the cuffs of size 3 and 4 LMAs respectively. In the ETT group 7.5mm tubes will be used for female patients and 8mm ETT will be used for male patients. Cuff pressure for ETT will be maintained with 5-7 ml of air ensuring that no air leak is audible.

Anaesthesia will be maintained in a standard manner , and discontinued at the request of the surgeon. The airway device will be removed at the appropriate time.


Inclusion criteria

  1. Age >18 years
  2. ASA I or ASA II risk category

Exclusion criteria

  1. ASA III or above
  2. BMI >25kg/m2
  3. Non consenting patients


Primary outcome(s)

1.
  1. Time taken to establish the airway
  2. Duration of the surgery
  3. Airway time
  4. Removal time( last stitch to airway removal)
  5. Awakening time( last stitch to responding to commands)
  6. Haemodynamic and respiratory variables : heart rate, blood pressure, respiratory rate, SpO2, EtCO2
  7. Complications of airway management devices : cough, laryngospasm, nausea, vomiting on emergence, subjective feeling of sore throat
  8. Other serious complications : pulmonary aspiration, negative pressure pulmonary oedema
[
  1. - 5. : During surgery and the recovery period
  2. : prior to induction, after anaesthetic induction prior to airway insertion, 2 minutes after airway insertion, prior to LMA or ETT removal, 2 minutes after the removal, at discharge from the theatre
  3. – 8. : from induction until discharge from the hospital
]

Secondary outcome(s)

1.

None

[

None

]

Target number/sample size

52 ( 26 per group)


Countries of recruitment

Sri Lanka


Anticipated start date

2013-04-01


Anticipated end date

2013-08-05


Date of first enrollment


Date of study completion


Recruitment status

Recruiting


Funding source

None


Regulatory approvals



State of Ethics Review Approval


Status

Approved


Date of Approval

2012-06-21


Approval number

EC-12-036


Details of Ethics Review Committee

Name: Ethics Review Committee, Faculty of Medicine, University of Colombo
Institutional Address:No. 25, Kynsey Road, Colombo 00800 Sri Lanka
Telephone:+94-11-2695300 (Extension: 240)
Email: ethicscommitteemfc@gmail.com

Contact & Sponsor Information


Contact person for Scientific Queries/Principal Investigator

Dr. Ajantha Perera
Consultant Anaesthetist
The National Hospital of Sri Lanka Colombo 10

+94712738750

ajantha_perera_2005@gmail.com

Contact Person for Public Queries

Dr. Ajantha Perera
Consultant Anaesthetist
The National Hospital of Sri Lanka Colombo 10

+94712738750

ajantha_perera_2005@gmail.com


Primary study sponsor/organization

National Hospital of Sri Lanka
Colombo 10

+94-112691111


http://www.nationalhospital.lk

Secondary study sponsor (If any)

None





Trial Completion details


Do the investigators plan to share identified individual clinical trial participant-level data (IPD)?


IPD sharing plan description


Study protocol available


Protocol version and date

Not Available


Protocol URL

Not Available


Results summary available

No


Date of posting results


Date of study completion


Final sample size


Date of first publication


Link to results


Brief summary of results